IPN60300
CLIN-60300-450
Phase 2 small_molecule active
Quick answer
IPN60300 for Advanced or metastatic solid tumours is a Phase 2 program (small_molecule) at Ipsen Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ipsen Pharma
- Indication
- Advanced or metastatic solid tumours
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active